Viewing Study NCT03386851


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-01-13 @ 8:18 PM
Study NCT ID: NCT03386851
Status: COMPLETED
Last Update Posted: 2022-02-14
First Post: 2017-12-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
None Bipolar 1 Disorder View
Keywords: